Hanna Azirar
Executive Director, Business Development
ICON
Is member of
ICON
Exhibitorsis attending
Off-Patent Semaglutide in 2026: The Next Revolution in Anti-Obesity Medications
Tuesday, October 28, 2025 12:15 PM to 12:40 PM
Hall 4.1 - 4.1J48
Aurelio Arias · IQVIA
Panel: From Collaboration to Commitment: Strengthening CRO-End User Relationships
Tuesday, October 28, 2025 10:35 AM to 11:20 AM
Hall 6.1 - 6.1C92
Arjen Akkerman · ICON
Peter Harrsch · Brandwidth Solutions
Enabling Dosing Flexibility in Early Phase Trials: An Integrated CMC and Manufacturing Strategy
Tuesday, October 28, 2025 1:15 PM to 1:40 PM
Hall 6.1 - 6.1C92
Suzanne Jansen · ICON
Unlocking Growth: Investment Trends in European Pharma Start-Ups
Tuesday, October 28, 2025 12:00 PM to 12:45 PM
Hall 4 - 4.0H56
Jan Vertommen · Lonza
Thomas Kern · ISP HEALTHCARE
The Newsbeat Stage: Exclusive Announcements From Pharma Leaders
Tuesday, October 28, 2025 11:30 AM to 12:20 PM
Hall 4.1 - 4.1L8
Raman Sehgal · Molecule to Market